Skip to content
Research Article Open access CC BY 3.0

Finding the Optimum Scenario in Risk-benefit Assessment: An Example on Vitamin D

F. L. Berjia, J. Hoekstra, H. Verhagen, M. Poulsen, R. Andersen, M. Nauta

European Journal of Nutrition & Food Safety · pp. 558–576 · Published 10 Aug 2014

10.9734/EJNFS/2014/9285

Abstract

Background: In risk-benefit assessment of food and nutrients, several studies so far have focused on comparison of two scenarios to weigh the health effect against each other. One obvious next step is finding the optimum scenario that provides maximum net health gains.  Aim: This paper aims to show a method for finding the optimum scenario that provides maximum net health gains.  Methods: A multiple scenario simulation. The method is presented using vitamin D intake in Denmark as an example. In addition to the reference scenario, several alternative scenarios are simulated to detect the scenario that provides maximum net health gains. As a common health metric, Disability Adjusted Life Years (DALY) has been used to project the net health effect by using the QALIBRA (Quality of Life for Benefit Risk Assessment) software. Results: The method used in the vitamin D example shows that it is feasible to find an optimum scenario that provides maximum net health gain in health risk-benefit assessment of dietary exposure as expressed by serum vitamin D level. With regard to the vitamin D assessment, a considerable health gain is observed due to the reduction of risk of other cause mortality, fall and hip fractures when changing from the reference to the optimum scenario.  Conclusion: The method allowed us to find the optimum serum level in the vitamin D example. Additional case studies are needed to further validate the applicability of the approach to other nutrients or foods, especially with regards to the uncertainty that is usually attending the data.

Optimum scenario vitamin D risk-benefit assessment DALY QALIBRA.

References (50)

  1. 1 The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know [DOI]
  2. 2 Dietary Reference Intakes for Calcium and Vitamin D [DOI]
  3. 3 Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [DOI]
  4. 4 Estimates of optimal vitamin D status [DOI]
  5. 5 Fracture Prevention With Vitamin D Supplementation [DOI]
  6. 6 Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women [DOI]
  7. 7 Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials [DOI]
  8. 8 Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency [DOI]
  9. 9 Vitamin D supplementation for prevention of mortality in adults [DOI]
  10. 10 Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice [DOI]
  11. 11 Optimal Vitamin D Status for Colorectal Cancer Prevention [DOI]
  12. 12 The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis [DOI]
  13. 13 Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies [DOI]
  14. 14 Vitamin D status and health correlates among German adults [DOI]
  15. 15 Vitamin D and cancer [DOI]
  16. 16 Which circulating level of 25-hydroxyvitamin D is appropriate? [DOI]
  17. 17 Benefit–risk assessment of vitamin D supplementation [DOI]
  18. 18 A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study [DOI]
  19. 19 Plasma vitamin D and mortality in older men: a community-based prospective cohort study [DOI]
  20. 20 Scientific Opinion on the Tolerable Upper Intake Level of vitamin D [DOI]
  21. 21 Estimation of the dietary requirement for vitamin D in healthy adults [DOI]
  22. 22 A framework for integrated environmental health impact assessment of systemic risks [DOI]
  23. 23 Estimation of the dietary requirement for vitamin D in free-living adults ≥64 y of age [DOI]
  24. 24 Vitamin D – a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations [DOI]
  25. 25 Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe [DOI]
  26. 26 Time trends of mortality after first hip fractures [DOI]
  27. 27 Risk‐Benefit Analysis of Seafood Consumption: A Review [DOI]
  28. 28 Mortality, disability, and falls in older persons: the role of underlying disease and disability. [DOI]
  29. 29 Mortality analysis in hip fracture patients: implications for design of future outcome trials [DOI]
  30. 30 Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate [DOI]
  31. 31 Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture [DOI]
  32. 32 State of the art in benefit–risk analysis: Food and nutrition [DOI]
  33. 33 Integrated risk–benefit analyses: Method development with folic acid as example [DOI]
  34. 34 Incidence and mortality of falls amongst older people in primary care in the United Kingdom [DOI]
  35. 35 Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study [DOI]
  36. 36 Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance [DOI]
  37. 37 Dose-Dependent Short-Term Effects of Single High Doses of Oral Vitamin D3 on Bone Turnover Markers [DOI]
  38. 38 Critical appraisal of the assessment of benefits and risks for foods, ‘BRAFO Consensus Working Group’ [DOI]
  39. 39 Application of the BRAFO tiered approach for benefit–risk assessment to case studies on dietary interventions [DOI]
  40. 40 A Tiered Approach for Risk-Benefit Assessment of Foods [DOI]
  41. 41 Qalibra: A general model for food risk–benefit assessment that quantifies variability and uncertainty [DOI]
  42. 42 Application of the BRAFO-tiered approach for benefit-risk assessment to case studies on natural foods [DOI]
  43. 43 Five-Year Survival in a Cohort of Hip Fracture Patients: The Predictive Role of Pre-fracture Health Status [DOI]
  44. 44 Albuminuria and Risk of Nonvertebral Fractures [DOI]
  45. 45 Vitamin D: A D-lightful solution for good health [DOI]
  46. 46 Incidence and characteristics of falls leading to hospital treatment: a one-year population surveillance study of the Danish population aged 45 years and over [DOI]
  47. 47 Application of the BRAFO tiered approach for benefit–risk assessment to case studies on heat processing contaminants [DOI]
  48. 48 D-vitamin:opdatering af videnskabelig evidens for sygdomsforebyggelse og anbefalinger
  49. 49 Food, nutrition, physical activity, and the prevention of cancer: a global perspective [DOI]
  50. 50 A meta-analysis of randomized controlled trials [DOI]

Cited by 10

Risk-benefit assessment

Jeljer Hoekstra, Maarten Nauta, Morten Poulsen · Present Knowledge in Food Safety · 2023

Meeting the challenges in the development of risk-benefit assessment of foods

Maarten J. Nauta, Rikke Andersen, Kirsten Pilegaard · Trends in Food Science & Technology · 2018

Risk-benefit in food safety and nutrition – Outcome of the 2019 Parma Summer School

Hans Verhagen, Cristina Alonso-Andicoberry, Ricardo Assunção · Food Research International · 2021

Risk Benefit Assessment of foods: Key findings from an international workshop

Sara M. Pires, Géraldine Boué, Alan Boobis · Food Research International · 2019

Showing 5 of 10 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

46

Page views

0

PDF downloads

24

Outbound clicks

10

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.